Baseline plasma C-reactive protein concentrations influence lipid and lipoprotein responses to low-fat and high monounsaturated fatty acid diets in healthy men. 2006

Sophie Desroches, and W Roodly Archer, and Marie-Eve Paradis, and Olivier Dériaz, and Patrick Couture, and Jean Bergeron, and Nathalie Bergeron, and Benoît Lamarche
Institute on Nutraceuticals and Functional Foods, Laval University, QC, Canada.

To date, no studies have compared the effects of consuming a low-fat diet and a high monounsaturated fatty acid (MUFA) diet, under unrestricted energy intake conditions, on plasma C-reactive protein (CRP) concentrations. Men [n = 61; 37.5 +/- 11.5 y old (mean +/- SD), mean BMI 29.0 +/- 5.0 kg/m2] were randomly assigned to consume ad libitum a moderately low-fat diet (25.8% of energy intake from fat) or a high-fat diet rich in MUFA (40.1% of energy intake from fat, 22.5% from MUFA) for 6-7 wk. Plasma CRP concentrations were measured using a highly sensitive assay. Neither diet affected the plasma CRP concentration. However, baseline CRP concentrations predicted lipoprotein/lipid responsiveness to the experimental diets. After intake of the low-fat diet, plasma total and VLDL-triglyceride (TG) concentrations were increased in the subgroup with high CRP concentrations (P < 0.05 and P < 0.01, respectively) whereas they were reduced in the subgroup with low CRP concentrations at baseline (P < 0.01 for both). The high-MUFA diet reduced plasma TG, VLDL-TG, and VLDL cholesterol only in the subgroup with low CRP at baseline (P < 0.0001). In conclusion, the low-fat diet and the high-MUFA diet did not affect plasma CRP concentrations. However, baseline plasma CRP concentrations may modulate the diet-induced changes in plasma lipid and lipoprotein concentrations.

UI MeSH Term Description Entries
D008055 Lipids A generic term for fats and lipoids, the alcohol-ether-soluble constituents of protoplasm, which are insoluble in water. They comprise the fats, fatty oils, essential oils, waxes, phospholipids, glycolipids, sulfolipids, aminolipids, chromolipids (lipochromes), and fatty acids. (Grant & Hackh's Chemical Dictionary, 5th ed) Lipid
D008074 Lipoproteins Lipid-protein complexes involved in the transportation and metabolism of lipids in the body. They are spherical particles consisting of a hydrophobic core of TRIGLYCERIDES and CHOLESTEROL ESTERS surrounded by a layer of hydrophilic free CHOLESTEROL; PHOSPHOLIPIDS; and APOLIPOPROTEINS. Lipoproteins are classified by their varying buoyant density and sizes. Circulating Lipoproteins,Lipoprotein,Lipoproteins, Circulating
D008079 Lipoproteins, VLDL A class of lipoproteins of very light (0.93-1.006 g/ml) large size (30-80 nm) particles with a core composed mainly of TRIGLYCERIDES and a surface monolayer of PHOSPHOLIPIDS and CHOLESTEROL into which are imbedded the apolipoproteins B, E, and C. VLDL facilitates the transport of endogenously made triglycerides to extrahepatic tissues. As triglycerides and Apo C are removed, VLDL is converted to INTERMEDIATE-DENSITY LIPOPROTEINS, then to LOW-DENSITY LIPOPROTEINS from which cholesterol is delivered to the extrahepatic tissues. Pre-beta-Lipoprotein,Prebeta-Lipoprotein,Prebeta-Lipoproteins,Very Low Density Lipoprotein,Very-Low-Density Lipoprotein,Very-Low-Density Lipoproteins,Lipoprotein VLDL II,Lipoproteins, VLDL I,Lipoproteins, VLDL III,Lipoproteins, VLDL1,Lipoproteins, VLDL2,Lipoproteins, VLDL3,Pre-beta-Lipoproteins,Lipoprotein, Very-Low-Density,Lipoproteins, Very-Low-Density,Pre beta Lipoprotein,Pre beta Lipoproteins,Prebeta Lipoprotein,Prebeta Lipoproteins,VLDL Lipoproteins,VLDL1 Lipoproteins,VLDL2 Lipoproteins,VLDL3 Lipoproteins,Very Low Density Lipoproteins
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002097 C-Reactive Protein A plasma protein that circulates in increased amounts during inflammation and after tissue damage. C-Reactive Protein measured by more sensitive methods often for coronary heart disease risk assessment is referred to as High Sensitivity C-Reactive Protein (hs-CRP). High Sensitivity C-Reactive Protein,hs-CRP,hsCRP,C Reactive Protein,High Sensitivity C Reactive Protein
D002149 Energy Intake Total number of calories taken in daily whether ingested or by parenteral routes. Caloric Intake,Calorie Intake,Intake, Calorie,Intake, Energy
D004042 Dietary Fats, Unsaturated Unsaturated fats or oils used in foods or as a food. Dietary Oils,Unsaturated Dietary Fats,Dietary Fat, Unsaturated,Dietary Oil,Fat, Unsaturated Dietary,Fats, Unsaturated Dietary,Oil, Dietary,Oils, Dietary,Unsaturated Dietary Fat
D005229 Fatty Acids, Monounsaturated Fatty acids which are unsaturated in only one position. Monounsaturated Fatty Acid,Acid, Monounsaturated Fatty,Acids, Monounsaturated Fatty,Fatty Acid, Monounsaturated,Monounsaturated Fatty Acids
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

Sophie Desroches, and W Roodly Archer, and Marie-Eve Paradis, and Olivier Dériaz, and Patrick Couture, and Jean Bergeron, and Nathalie Bergeron, and Benoît Lamarche
July 2000, The American journal of clinical nutrition,
Sophie Desroches, and W Roodly Archer, and Marie-Eve Paradis, and Olivier Dériaz, and Patrick Couture, and Jean Bergeron, and Nathalie Bergeron, and Benoît Lamarche
April 2009, The Journal of nutrition,
Sophie Desroches, and W Roodly Archer, and Marie-Eve Paradis, and Olivier Dériaz, and Patrick Couture, and Jean Bergeron, and Nathalie Bergeron, and Benoît Lamarche
December 1999, The American journal of clinical nutrition,
Sophie Desroches, and W Roodly Archer, and Marie-Eve Paradis, and Olivier Dériaz, and Patrick Couture, and Jean Bergeron, and Nathalie Bergeron, and Benoît Lamarche
March 1992, The American journal of clinical nutrition,
Sophie Desroches, and W Roodly Archer, and Marie-Eve Paradis, and Olivier Dériaz, and Patrick Couture, and Jean Bergeron, and Nathalie Bergeron, and Benoît Lamarche
March 1998, The American journal of clinical nutrition,
Sophie Desroches, and W Roodly Archer, and Marie-Eve Paradis, and Olivier Dériaz, and Patrick Couture, and Jean Bergeron, and Nathalie Bergeron, and Benoît Lamarche
June 2001, The Journal of nutrition,
Sophie Desroches, and W Roodly Archer, and Marie-Eve Paradis, and Olivier Dériaz, and Patrick Couture, and Jean Bergeron, and Nathalie Bergeron, and Benoît Lamarche
September 2008, The British journal of nutrition,
Sophie Desroches, and W Roodly Archer, and Marie-Eve Paradis, and Olivier Dériaz, and Patrick Couture, and Jean Bergeron, and Nathalie Bergeron, and Benoît Lamarche
November 1995, Lipids,
Sophie Desroches, and W Roodly Archer, and Marie-Eve Paradis, and Olivier Dériaz, and Patrick Couture, and Jean Bergeron, and Nathalie Bergeron, and Benoît Lamarche
July 1997, Lipids,
Sophie Desroches, and W Roodly Archer, and Marie-Eve Paradis, and Olivier Dériaz, and Patrick Couture, and Jean Bergeron, and Nathalie Bergeron, and Benoît Lamarche
January 1983, Metabolism: clinical and experimental,
Copied contents to your clipboard!